Retension Pharmaceuticals, Inc. (NASDAQ:RTSN) IPO

Retension Pharmaceuticals, Inc.

IPO

Priced at US$12.00 a share on Oct 8, 2026.

Price
US$12.00 a share
Shares offered
3,750,000 shares of common stock
Offering size
US$45 million
Underwriters' option
Up to 562,500 more shares
Listing
RTSN on the Nasdaq Capital Market
Underwriters
Leerink Partners, Guggenheim Securities, Oppenheimer & Co., Titan Partners · In the order on the cover
Shares delivered
On or about Oct 13, 2026

Steps

StepWhen
Draft sent to the SEC in confidenceFeb 17, 2026
Filed publiclySep 18, 2026
Amended twiceNewest Oct 7, 2026
Shares registered with an exchangeOct 8, 2026
Declared effective by the SECOct 8, 2026
Final prospectus, with the priceOct 9, 2026

From the cover of the final prospectus (424B4) filed Oct 9, 2026